Spero named president, chief business officer at ProThera Biologics

DENICE M. SPERO has been appointed president and chief business officer of ProThera Biologics. / COURTESY PROTHERA BIOLOGICS
DENICE M. SPERO has been appointed president and chief business officer of ProThera Biologics. / COURTESY PROTHERA BIOLOGICS
PROVIDENCE – ProThera Biologics has appointed Denice M. Spero as president and chief business officer. ProThera Biologics is a biomedical company developing therapies to treat life-threatening diseases. Spero, according to the company, will strengthen its efforts to advance its inter-alpha inhibitor proteins into clinical development. She also will assume a leadership role in business development…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -